drugset / Trial / NCT03652636

Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

NCT03652636

Phase 4 Completed 47 enrolled Indiana University
NaSingle-groupOpen-labelDiagnostic

Summary

In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.

Timeline

Start
2019-08-05
Primary completion
2023-07-21
Completion
2023-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 2.5 ml Intravenous

Indications